White paper
January 17, 2024

AAV Production in Culture Biosciences’ 250mL Bioreactors

Gene therapy manufacturing is often challenged by gaps in process understanding and lack of process robustness. Large-scale exploration of design space early in process development can help set foundation for robust manufacturing by identifying key process parameters. On-demand fleets of small-scale bioreactors by Culture Biosciences enable scientists to run large experiments with real-time data transparency. Download this App Note to learn about:

- Carrying out AAV upstream process development in Culture Biosciences' 250mL proprietary bioreactors

- Increase the fraction of full AAV capsids through process optimization

Complete the form to download the full PDF

Keep exploring

White paper

A Reproducible and Scalable System for CHO Cell Culture

White paper

Supplemental Bioreactor Capacity Accelerates Bioprocess Development